Plus Therapeutics CEO gains 361,313 shares from RSUs
PLUS THERAPEUTICS, INC.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PLUS THERAPEUTICS, INC. Chief Executive Officer Marc H. Hedrick exercised restricted stock units into common shares in a compensation-related transaction. He acquired a total of 361,313 shares of Common Stock on April 1, 2026 through derivative exercises at a per-share price of $0.00.
The filing shows two RSU conversions of 159,681 and 201,632 units, each RSU representing a contingent right to one common share. Following these transactions, Hedrick directly holds 701,100 shares of Common Stock. The transactions involve no open-market purchases or sales and reflect the vesting and settlement of prior equity awards.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 159,681 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 201,632 | $0.00 | $0.00 |
| Exercise | Common Stock | 159,681 | $0.00 | $0.00 |
| Exercise | Common Stock | 201,632 | $0.00 | $0.00 |
Footnotes (3)
- F1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the issuer's Common Stock.
- F2. Represents the vesting of an RSU grant which occurs in twelve substantially equal quarterly installments beginning on October 1, 2025.
- F3. Represents the vesting of an RSU grant which occurs in twelve substantially equal quarterly installments beginning on April 1, 2026.
Key Figures
Key Terms
Restricted Stock Units financial
contingent right financial
vesting financial
exercise or conversion of derivative security financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did PSTV CEO Marc Hedrick report in this Form 4 filing?
Were there any open-market buys or sells by PSTV’s CEO in this Form 4?
What do the exercised restricted stock units represent for Plus Therapeutics (PSTV)?
Is the CEO’s RSU exercise in PSTV a routine compensation event?
AI-generated analysis. How Rhea-AI works. Not financial advice.